The U.S. Food and Drug Administration has demanded additional data from Novartis SA before approving a new type of diabetes drug, the Swiss pharmaceutical company said Monday.
Read full story
BOSTON (MarketWatch) — The Food and Drug Administration has informed Novartis AG that it needs an additional clinical data before it can approve the company’s diabetes drug Galvus, a move that analysts say could delay the drug’s approval by up to a year.
Read full story
BERKELEY HEIGHTS — The Joseph E. Enright Foundation and Summit Medical Group will continue their community health lecture series March 22 on “Diabetes in the 21st Century — Diagnosis and Treatment.”
Read full story
Anne Hummel, RN and Certified Diabetes Educator will be teaching her 12 hour course in diabetes self care and management at the Douglas Area Food Bank on Wednesday afternoons from 2 pm to 4 pm starting March 7 through April 12.
Read full story
